AC
Insider buying
Adar1 Capital Management, Llc bought $57K of InMed Pharmaceuticals Inc. (INM) stock
Adar1 Capital Management, Llc, 10% owner of InMed Pharmaceuticals Inc. (INM), bought 42,920 shares of INM stock worth $57K, per an SEC Form 4 filed Oct 5, 2026.
It was an open-market purchase.
The trade happened on Oct 1, 2026, 4 days before it was made public.
INM has moved +0.0% since the trade date, from $1.35 to $1.35 (Oct 1, 2026 close).
- Traded
- Oct 1, 2026
- Disclosed
- Oct 5, 2026
- Filing delay
- 4 days
- Price since
- +0.0%
- Role
- 10% owner
- Source
- SEC Form 4
More INM insider and Congress trades
- BuyINM · Adar1 Capital Management, Llc$118KSep 16, 2026
- BuyINM · Vivo Opportunity, Llc$32KJul 17, 2026
- BuyINM · Adar1 Capital Management, Llc$2KJul 17, 2026
- BuyINM · Vivo Opportunity, Llc$10KJul 2, 2026
- BuyINM · Vivo Opportunity, Llc$392KJun 11, 2026
- BuyINM · Adar1 Capital Management, Llc$722KMay 21, 2026
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.